TCMVX | VMVAX | TCMVX / VMVAX | |
Total Expense Ratio | 0.81 | 0.07 | 1,157% |
Annual Report Gross Expense Ratio | 0.81 | 0.07 | 1,157% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 5.549 | 5.909 | 94% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.56B | 32.5B | 5% |
Annual Yield % from dividends | 1.32 | 2.17 | 61% |
Returns for 1 year | -2.20 | 1.58 | -140% |
Returns for 3 years | 18.60 | 40.47 | 46% |
Returns for 5 years | 28.52 | 62.06 | 46% |
Returns for 10 years | -17.04 | 98.70 | -17% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DFUV | 44.45 | 0.36 | +0.82% |
Dimensional US Marketwide Value ETF | |||
HEZU | 42.58 | 0.11 | +0.26% |
iShares Currency Hedged MSCI Eurozn ETF | |||
USML | 42.11 | N/A | N/A |
ETRACS 2x Lvrgd MSCI US Mn Vl Fct TR ETN | |||
APRW | 34.20 | -0.03 | -0.09% |
AllianzIM US Large Cap Buffer20 Apr ETF | |||
OZEM | 28.13 | -0.45 | -1.56% |
Roundhill GLP-1 & Weight Loss ETF |